8-K: Reliance Global Amends ATM Offering Prospectus
Amendment to Prospectus Supplement
Reliance Global Group, Inc. filed an amendment to its prospectus supplement for an At The Market offering, allowing for the sale of up to $1.76 million in common stock.
Summary
- Reliance Global Group, Inc. (RELI) filed Amendment No. 3 to its prospectus supplement on February 6, 2026, related to an At The Market (ATM) Offering Agreement.
- The amendment allows the company to offer and sell up to an aggregate of $1,764,443 of its common stock through H.C. Wainwright & Co., LLC.
- The company had previously offered and sold $2,343,660 of common stock pursuant to Form S-3 during the 12 calendar months prior to and including February 6, 2026.
- Zarif Law Group P.C. provided a legal opinion confirming that the shares are duly authorized and, when issued and paid for, will be validly issued, fully paid, and non-assessable.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative update. While it facilitates capital raising, which can be positive for liquidity, it also implies potential dilution for existing shareholders, balancing the overall sentiment.
Positives
- The legal opinion confirms that the shares offered under the ATM program are duly authorized, validly issued, fully paid, and non-assessable, providing legal certainty for investors.
- The ATM offering mechanism provides the company with a flexible and efficient way to raise capital as needed, supporting ongoing operations or strategic initiatives.
Negatives
- The ATM offering, if fully utilized, will result in dilution for existing shareholders as new shares are issued into the market.
- The continuous nature of an ATM offering can create potential downward pressure on the stock price due as new shares become available for sale.
Risks
- Dilution of existing shareholders' ownership percentage and earnings per share due to the issuance of new common stock under the At The Market offering.
- Potential downward pressure on the company's stock price as shares are sold into the market through the ATM program.
Future Outlook
The filing indicates the company's intent to continue utilizing its At The Market offering facility to raise capital by selling shares of common stock from time to time, up to the amended aggregate offering price.
Management Comments
- The registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Industry Context
StockSavvy.ai notes that At The Market (ATM) offerings are a common and flexible capital-raising tool for publicly traded companies, particularly smaller-cap firms. They allow companies to raise capital incrementally over time, often at prevailing market prices, minimizing the immediate price impact compared to a large, fixed-price offering. This approach is frequently used to fund general corporate purposes, working capital, or specific growth initiatives, reflecting a strategic decision to maintain financial flexibility.
Comparison to Industry Standards
- This ATM offering structure is standard practice for companies seeking to raise capital efficiently. Many biotech and technology companies frequently use ATM facilities to fund research and development or operational expenses, similar to how companies like Sorrento Therapeutics (SRNE) or Aeterna Zentaris (AEZS) have historically utilized such programs.
- The legal opinion regarding the validity of shares is a standard requirement for such offerings, ensuring compliance with SEC regulations and investor protection.
- The aggregate offering amount of $1.76 million is relatively small, suggesting a targeted capital need rather than a major strategic shift, which is common for companies of Reliance Global Group's size.
Stakeholder Impact
- Shareholders: Potential dilution of ownership and earnings per share as new shares are issued. The ATM mechanism allows for gradual sales, which might mitigate immediate price shock compared to a large secondary offering.
- Company (Management/Operations): Provides access to capital for general corporate purposes, working capital, or strategic initiatives, enhancing financial flexibility.
- Investors (Potential): Offers an opportunity to purchase shares directly from the company at market prices, though the timing and pricing are at the company's discretion.
Next Steps
- The company will continue to offer and sell shares of common stock from time to time under the At The Market Offering Agreement.
- Future amendments or supplements to the ATM Prospectus may be filed as needed.
Key Dates
| Date | Description |
|---|---|
| 2023-11-07 | Date of the original Base Prospectus. |
| 2025-08-13 | Date of the initial Prospectus Supplement and the At The Market Offering Agreement. |
| 2025-09-18 | Date of Amendment No. 1 to the prospectus supplement. |
| 2025-12-15 | Date of Amendment No. 2 to the prospectus supplement. |
| 2026-02-06 | Date of earliest event reported and filing of Amendment No. 3 to the prospectus supplement. |
| 2026-02-09 | Date the Form 8-K was signed by the Chief Executive Officer. |
Recommendation
holdThis filing is an administrative update to an existing At The Market offering, not a new strategic development or a significant financial performance report. While it confirms the company's ability to raise capital, it also signals potential ongoing dilution. Without further operational or financial news, this update alone does not warrant a change in investment stance for a seasoned investor; it merely confirms the continuation of a known capital-raising strategy.
Keywords
Reliance Global Group, RELI, ATM offering, At The Market, common stock, equity offering, prospectus supplement, capital raise, SEC filing, Form 8-K, H.C. Wainwright & Co., dilution
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.